Armata Pharmaceuticals Q4 EPS $(0.55) Misses $(0.35) Estimate, Sales $1.53M Beat $860.00K Estimate
Portfolio Pulse from Happy Mohamed
Armata Pharmaceuticals (AMEX:ARMP) reported Q4 earnings with a per-share loss of $(0.55), missing the $(0.35) estimate, marking a 57.14% miss and an 89.66% increase in losses from the previous year. However, their quarterly sales of $1.53M exceeded expectations by 77.67%, showing a 45.39% increase from the previous year.
March 21, 2024 | 8:07 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Armata Pharmaceuticals reported a larger than expected Q4 loss per share but exceeded sales forecasts.
The mixed results with a significant earnings miss but a strong sales beat could lead to neutral short-term stock price movement. Investors might be concerned about the increased losses but could be optimistic about the higher sales.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100